$10.33
At close: Dec 18, 5:59 PM EDT
$10.25
-0.08-0.77%
After Hours: 5:59 PM EDT
Avadel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Avadel Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.03 | $-0.05 | 40.0 % |
Jun 2024 | 2024-08-08 | $-0.14 | $-0.16 | 12.5 % |
Mar 2024 | 2024-05-08 | $-0.30 | $-0.21 | -42.9 % |
Dec 2023 | 2024-03-04 | $-0.32 | $-0.29 | -10.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $50.03M | $48.61M | 2.91 % |
Jun 2024 | 2024-08-08 | $41.50M | $37.58M | 10.4 % |
Mar 2024 | 2024-05-08 | $27.18M | $26.67M | 1.90 % |
Dec 2023 | 2024-03-04 | $19.45M | $18.11M | 7.42 % |
Avadel Pharmaceuticals (AVDL) is scheduled to report earnings on March 3, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.03, which beat the estimate of $-0.05.
The Actual Revenue was $50M, which beat the estimate of $48.6M.
Browse earnings estimates, EPS, and revenue on all stocks.